Trans-Cevimeline Hydrochloride
Trans-Cevimeline Hydrochloride | CAS NO: 107220-29-1 also known as Trans-Cevimeline Hydrochloride its chemical | IUPAC name is Trans-2’-Methyl-spiro[1-azabicyclo[2.2.2]octane-3,5’-[1,3]oxathiolane] Hydrochloride Trans-Cevimeline Hydrochloridepotential impurity of Cevimeline Cevimeline is a medication primarily used to treat symptoms of dry mouth (xerostomia), especially in patients with Sjögren's syndrome, a condition where the immune system attacks the glands that produce moisture, like salivary glands.Synchemia Research chemical is manufacturer to regulatory guidelines, ensuring its suitability for pharmaceutical QC applications.
Synchemia Research chemical is a leading manufacturer, Supplier and exporter of high-quality Trans-Cevimeline Hydrochloride| CAS NO: 107220-29-1also known as Trans-Cevimeline Hydrochloride Cevimeline can also be used for other conditions where dry mouth is a major issue, such as in patients undergoing radiation therapy for head and neck cancers, though it's primarily associated with Sjögren's syndrome. Buy Reliable and High-Purity of Cevimeline Delivered by Synchemia Research Chemical.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-C2121 |
| CAS No | 107233-08-9 |
| Mol.F. | C10H17NOS |
| Mol.Wt. | 199.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2122 |
| CAS No | 61573-79-3 |
| Mol.F. | C8H15NO2 |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2124 |
| CAS No | 469890-14-0 |
| Mol.F. | C10H17NO2S |
| Mol.Wt. | 215.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2125 |
| CAS No | NA |
| Mol.F. | C27H29NOS |
| Mol.Wt. | 415.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2126 |
| CAS No | 61573-79-3 |
| Mol.F. | C8H15NO2 : HCl |
| Mol.Wt. | 157.2 : 36.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-C2127 |
| CAS No | 107220-26-8 |
| Mol.F. | C8H15NOS |
| Mol.Wt. | 173.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-C2128 |
| CAS No | NA |
| Mol.F. | C10H17NO2S |
| Mol.Wt. | 215.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2129 |
| CAS No | 124751-37-7 |
| Mol.F. | C10H17NO2S |
| Mol.Wt. | 215.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2130 |
| CAS No | 124751-36-6 |
| Mol.F. | C10H17NO2S |
| Mol.Wt. | 215.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2131 |
| CAS No | NA |
| Mol.F. | C14H20N2O |
| Mol.Wt. | 232.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2132 |
| CAS No | 1434122-45-8 |
| Mol.F. | C16H28N2O2S |
| Mol.Wt. | 312.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2133 |
| CAS No | NA |
| Mol.F. | C10H17NO3S |
| Mol.Wt. | 231.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2134 |
| CAS No | NA |
| Mol.F. | C20H32N2O4S2 |
| Mol.Wt. | 428.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2135 |
| CAS No | 1434122-43-6 |
| Mol.F. | C16H28N2O2S2 |
| Mol.Wt. | 344.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2136 |
| CAS No | NA |
| Mol.F. | C18H32N2O2S2 |
| Mol.Wt. | 372.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-C2137 |
| CAS No | NA |
| Mol.F. | C18H30N2O3S2 |
| Mol.Wt. | 386.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |